首页 | 本学科首页   官方微博 | 高级检索  
检索        

分子靶向抗肿瘤药物皮肤不良反应研究进展
引用本文:石艾秀,曹双林.分子靶向抗肿瘤药物皮肤不良反应研究进展[J].中国麻风皮肤病杂志,2021,37(9):605-609.
作者姓名:石艾秀  曹双林
作者单位:1宿迁市第一人民医院皮肤科,江苏宿迁,223800;2南通大学附属医院皮肤科,江苏南通,226001
摘    要:近年来靶向抗肿瘤药物的使用在恶性肿瘤治疗中逐渐广泛,显著提高了患者生存率,但其引起的皮肤不良反应十分常见。根据作用靶点的不同对靶向药物不良反应进行分类分析,可找出其中的共性与个性,为皮肤科及肿瘤科医生提供诊疗的新思路。本文将分别从细胞膜相关抑制剂、胞内信号通路抑制剂及免疫检测点抑制剂三个方面综述临床上较为常见的靶向药物相关皮肤不良反应的类型及其处理措施。

关 键 词:靶向治疗  免疫治疗  不良反应  皮肤  

Advance of skin adverse reactions caused by molecular targeted anti-tumor drugs
SHI Aixiu,CAO Shuanglin.Advance of skin adverse reactions caused by molecular targeted anti-tumor drugs[J].China Journal of Leprosy and Skin Diseases,2021,37(9):605-609.
Authors:SHI Aixiu  CAO Shuanglin
Institution:1 Department of Dermatology, Suqian First Hospital, Suqian 223800, China; 2 Department of Dermatology, Affiliated Hospital of Nantong University, Nantong 226001, China
Abstract:In recent years, the use of targeted anti-tumor drugs has gradually occupied a pivotal position in the treatment of malignant tumors. The widespread application of targeted therapies can significantly improve the survival rate of patients, but the adverse skin reactions(ASR) caused by them are common. Classification and analysis of ASR caused by targeted drugs according to different targets can find commonalities and personalities, and provide new ideas for diagnosis and treatment for dermatologists and oncologists. The types of ASR caused by targeted drugs and their treatment measures of cell membrane-related inhibitors, intracellular signaling inhibitors, and immune checkpoint inhibitors are reviewed in this article.
Keywords:targeted therapy  immunotherapy  adverse reactions  skin  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国麻风皮肤病杂志》浏览原始摘要信息
点击此处可从《中国麻风皮肤病杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号